ERICA FRISCH: Open Payments
NPI 1982952966 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,156 in 162 payments from 39 companies in 2025. Trend: 2023 $2,578 · 2024 $4,990 · 2025 $3,156
Food & beverage: $3,156
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 17 | $413 |
| Xeris Pharmaceuticals, Inc. | 20 | $381 |
| Novo Nordisk Inc | 24 | $238 |
| BETA BIONICS, INC. | 11 | $181 |
| Lilly USA, LLC | 9 | $176 |
| Amgen Inc. | 9 | $153 |
| Abbott Laboratories | 7 | $133 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| Neurocrine BioSciences, Inc. | 5 | $120 |
| Insulet Corporation | 2 | $91 |
Products named: Dexcom G6 Transmitter, GVOKE HYPOPEN, iLet Bionic Pancreas, EVENITY, FREESTYLE LIBRE 3, LEQVIO, CRENESSITY, JARDIANCE.
Industry payments across OH — which companies pay providers there.
